Dr. Jahan Marcu gives research-based evidence on vape pen use and the EVALI situation, separating fact from conjecture on the vape pen crisis. Currently, there is a lack of information for physicians as to what constitutes safe use for patients and consumers. Further testing on vaporization needs to be done to ensure safety. Marcu hopes industry professionals will educate regulators.
Dr. Marcu has over 15 years of experience in cannabis research with a focus on cannabis pharmacology and cannabinoid receptor function. He has been reporting on the potential issues with vape pens since 2015.